VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting <i>BRAF</i><sup>V600E</sup> Mutation in Papillary Thyroid Cancer.

Choden, Sonam; Keelawat, Somboon; Jung, Chan Kwon; Bychkov, Andrey

VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAF^V600E Mutation in Papillary Thyroid Cancer.

Choden, Sonam; Keelawat, Somboon; Jung, Chan Kwon; Bychkov, Andrey.

Afiliación

Choden S; Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Keelawat S; Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Jung CK; Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Bychkov A; Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

Cancers (Basel) ; 12(3)2020 Mar 05.

Article en En | MEDLINE | ID: mdl-32150939

Palabras clave

BRAF; VE1; diagnostic performance; immunohistochemistry; papillary thyroid carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google